Diagnostic accuracy of fat pad sampling and bone marrow biopsy for AL amyloidosis: a systematic review and meta-analysis.
文献摘要
Abstract In this systematic review, we aimed to assess the diagnostic test accuracy of abdominal fat pad sampling and bone marrow biopsy for immunoglobulin light-chain amyloidosis using organ biopsy as the reference standard. We searched the literature using PubMed, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) databases from inception to March 2024. We used Quality Assessment of Diagnostic Accuracy Studies-2 to assess the risk of bias and the Grading of Recommendations Assessment, Development, and Evaluation approach to assess the certainty of evidence. After deduplication, 29 237 records were screened and 31 studies were included. Among the studies, 25 (n = 4649) reported on fat pad sampling, with a pooled sensitivity of 0.77 (95% confidence interval, 0.72-0.81), whereas 20 (n = 2771) reported on bone marrow biopsy, with a pooled sensitivity of 0.55 (0.46-0.63). All studies enrolled patients with confirmed disease; specificity was not reported in the included studies. Fat pad aspiration (15 studies, n = 1590) and surgical or punch biopsy (4 studies, n = 222) had similar sensitivities of 0.80 (0.76-0.83) and 0.77 (0.61-0.88), respectively. In a single study (n = 612), performing both tests together yielded a sensitivity of 0.89. Certainty of evidence was judged to be moderate for fat pad sampling and low for bone marrow biopsy.